Evidence map›Paper›PMID 31037736›Full record

SynthesisInternational journal of cancer2020

Meta-analysis of 16 studies of the association of alcohol with colorectal cancer.

Sarah McNabb, Tabitha A Harrison, Demetrius Albanes, Sonja I Berndt, Hermann Brenner, Bette J Caan, Peter T Campbell, Yin Cao, Jenny Chang-Claude, Andrew Chan and 32 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in International journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 3 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 3 syntheses or guidelines pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. [Ethanol promotes oxaliplatin resistance in colorectal cancer by activating the TGF‑β/Smad/P21 signaling axis].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Black-White disparities across the colorectal cancer care continuum in the USA.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 8 countries.

Sarah McNabbPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.ORCID 0000-0002-4562-2933
Tabitha A HarrisonPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Demetrius AlbanesDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Sonja I BerndtDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
Bette J CaanDivision of Research, Kaiser Permanente Medical Research Program, Oakland, CA.
Peter T CampbellEpidemiology Research Program, American Cancer Society, New York, NY.
Yin CaoDivision of Public Health Sciences, Washington University in St Louis, St. Louis, MO.
Jenny Chang-ClaudeUnit of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Andrew ChanDivision of Gastroenterology, Massachusetts General Hospital, Boston, MA.
Zhengyi ChenCenter for Community Health Integration, Case Western Reserve University School of Medicine, Cleveland, OH.
Dallas R EnglishCentre for Epidemiology and Biostatistics, School of Population & Global Health, University of Melbourne, Melbourne, VIC, Australia.
Graham G GilesCentre for Epidemiology and Biostatistics, School of Population & Global Health, University of Melbourne, Melbourne, VIC, Australia.
Edward L GiovannucciChanning Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Phyllis J GoodmanSWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA.
Richard B HayesDivision of Epidemiology, Department of Population Health, New York University School of Medicine, New York, NY.
Michael HoffmeisterDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-8307-3197
Eric J JacobsEpidemiology Research Program, American Cancer Society, New York, NY.
Amit D JoshiDepartment of Epidemiology, Harvard School of Public Health, Boston, MA.
Susanna C LarssonInstitute of Environmental Medicine, Karolinska Institutet, Solna, Sweden.
Loïc Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, HI.
Li LiDepartment of Family Medicine, University of Virginia, Charlottesville, VA.
Yi LinPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Satu MännistöPublic Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
Roger L MilneCentre for Epidemiology and Biostatistics, School of Population & Global Health, University of Melbourne, Melbourne, VIC, Australia.
Hongmei NanDepartment of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN.
Christina C NewtonBehavioral and Epidemiology Research Group, American Cancer Society, New York, NY.
Shuji OginoProgram in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Patrick S ParfreyClinical Epidemiology Unit, Memorial University Faculty of Medicine, St. John's, NL, Canada.ORCID 0000-0001-9576-0923
Paneen S PetersenFred Hutchinson Cancer Research Center, Seattle, WA.
John D PotterPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Robert E SchoenDepartment of Medicine and Epidemiology, University of Pittsburgh Medical Center, Hermitage, PA.
Martha L SlatteryDepartment of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT.ORCID 0000-0002-1655-6543
Yu-Ru SuPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Catherine M TangenPublic Health Sciences Division, Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA.
Thomas C TuckerMarkey Cancer Center, Lexington, KY.
Stephanie J WeinsteinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Emily WhitePublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Alicja WolkInstitute of Environmental Medicine, Karolinska Institutet, Solna, Sweden.
Michael O WoodsDiscipline of Genetics, Memorial University of Newfoundland, St. John's, NL, Canada.
Amanda I PhippsPublic Health Sciences Division, Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA.
Ulrike PetersPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAAmerican Cancer Society · USGerman Cancer Research Center · DEThe University of Melbourne · AUBrigham and Women's Hospital · USMemorial University of Newfoundland · CANational Cancer Institute · USBroad Institute · USCase Western Reserve University · USFinnish Institute for Health and Welfare · FIHarvard University · USHermitage Museum · USIndiana University Health · USKaiser Permanente Oakland Medical Center · USKarolinska Institutet · SENational Institutes of Health · USNew York University · USUniversity of Hawaiʻi at Mānoa · USUniversity of Kentucky · USUniversity of Utah · US

Funding

SWOG Foreign AccrualsU10CA037429 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BLANKE, CHARLES D., MEYSKENS, FRANK L. · 1985 to 2014
$205.2M
SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSNER, BERNARD A · 2000 to 2019
$77.8M
Validity of Diet and Activity Measures in WomenP01CA055075 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GIOVANNUCCI, EDWARD · 1991 to 2009
$41.8M
University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
Understanding Population Differences in Cancer: The MEC StudyU01CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HAIMAN, CHRISTOPHER ALAN, LE MARCHAND, LOIC · 2015 to 2025
$37.4M
Tissue and Pathology ResourcesP50CA127003 · NCI · DANA-FARBER CANCER INST · PI BASS, ADAM JOEL · 2007 to 2023
$33.2M
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) StudyZIACP010195 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ALBANES, DEMETRIUS · 2009 to 2025
$22.5M
Life Course Cancer Epidemiology Cohort in WomenU01CA176726 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI ELIASSEN, A. HEATHER, WILLETT, WALTER C. · 2018 to 2025
$22.4M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Molecular pathological epidemiology of colorectal cancerU01CA137088 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2009 to 2018
$21.8M
Cancer Epidemiology Cohort in Male Health ProfessionalsU01CA167552 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Lorelei Mucci, Walter C. Willett · 2017 to 2026
$17.0M
NCI NIH HHS 5UM1CA182883NCI NIH HHS HHSN261201500005CNCI NIH HHS K05 CA154337NCI NIH HHS K07 CA190673NCI NIH HHS P01 CA055075NCI NIH HHS P01 CA087969NCI NIH HHS P20 CA233216NCI NIH HHS P30 CA177558NCI NIH HHS P50 CA127003NCI NIH HHS R01 CA048998NCI NIH HHS R01 CA059045NCI NIH HHS R01 CA060987NCI NIH HHS R01 CA120582NCI NIH HHS R01 CA136726NCI NIH HHS R01CA136726NCI NIH HHS R01 CA137178NCI NIH HHS R01 CA151993NCI NIH HHS R01 CA201407NCI NIH HHS R01 CA206279NCI NIH HHS R35 CA197735NCI NIH HHS R35 CA253185NCI NIH HHS RFA # CA-09-002 U19 CA148107NCI NIH HHS U01 CA074783NCI NIH HHS U01 CA137088NCI NIH HHS U01 CA164930NCI NIH HHS U01 CA164973NCI NIH HHS U01 CA167552NCI NIH HHS U01 CA176726NCI NIH HHS U01 CA182883NCI NIH HHS U10 CA037429NCI NIH HHS U10CA37429NCI NIH HHS U19 CA148107NCI NIH HHS UG1 CA189974NCI NIH HHS UM1 CA167552NCI NIH HHS UM1 CA182883NCI NIH HHS UM1 CA186107NHLBI NIH HHS HHSN268201100001CNHLBI NIH HHS HHSN268201100001INHLBI NIH HHS HHSN268201100002CNHLBI NIH HHS HHSN268201100002INHLBI NIH HHS HHSN268201100003CNHLBI NIH HHS HHSN268201100003INHLBI NIH HHS HHSN268201100004CNHLBI NIH HHS HHSN268201100004INHLBI NIH HHS HHSN268201100046CNHLBI NIH HHS HHSN271201100004CNIA NIH HHS HHSN271201100004CNIH HHS K07 CA190673NIH HHS P01 CA055075NIH HHS P01 CA087969NIH HHS P50 CA127003NIH HHS R01 CA137178NIH HHS R01 CA151993NIH HHS R01 CA48998NIH HHS R01 CA60987NIH HHS R35 CA197735NIH HHS U01 CA164973NIH HHS U01 CA167552NIH HHS U01 CA74783NIH HHS UM1 CA167552NIH HHS UM1 CA186107WHI NIH HHS HHSN268201100001CWHI NIH HHS HHSN268201100002CWHI NIH HHS HHSN268201100003CWHI NIH HHS HHSN268201100004C
6 · The paper itself

Abstract

Alcohol consumption is an established risk factor for colorectal cancer (CRC). However, while studies have consistently reported elevated risk of CRC among heavy drinkers, associations at moderate levels of alcohol consumption are less clear. We conducted a combined analysis of 16 studies of CRC to examine the shape of the alcohol-CRC association, investigate potential effect modifiers of the association, and examine differential effects of alcohol consumption by cancer anatomic site and stage. We collected information on alcohol consumption for 14,276 CRC cases and 15,802 controls from 5 case-control and 11 nested case-control studies of CRC. We compared adjusted logistic regression models with linear and restricted cubic splines to select a model that best fit the association between alcohol consumption and CRC. Study-specific results were pooled using fixed-effects meta-analysis. Compared to non-/occasional drinking (≤1 g/day), light/moderate drinking (up to 2 drinks/day) was associated with a decreased risk of CRC (odds ratio [OR]: 0.92, 95% confidence interval [CI]: 0.88-0.98, p = 0.005), heavy drinking (2-3 drinks/day) was not significantly associated with CRC risk (OR: 1.11, 95% CI: 0.99-1.24, p = 0.08) and very heavy drinking (more than 3 drinks/day) was associated with a significant increased risk (OR: 1.25, 95% CI: 1.11-1.40, p < 0.001). We observed no evidence of interactions with lifestyle risk factors or of differences by cancer site or stage. These results provide further evidence that there is a J-shaped association between alcohol consumption and CRC risk. This overall pattern was not significantly modified by other CRC risk factors and there was no effect heterogeneity by tumor site or stage.

Indexed as

AgedAlcohol DrinkingCase-Control StudiesColorectal NeoplasmsEthanolFemaleHumansLife StyleMaleMiddle AgedOdds RatioProspective StudiesRisk FactorsEthanolalcoholcolon cancercolorectal cancerrectal cancer

Identifiers

PMID31037736
PMCPMC6819207
OpenAlexW2943631130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.